Michael LaBarre
Chief Tech/Sci/R&D Officer chez HALOZYME THERAPEUTICS, INC.
Fortune : 7 M $ au 31/03/2024
Profil
Michael J. LaBarre est directeur technique et vice-président principal de Halozyme Therapeutics, Inc. Au cours de sa carrière, le Dr LaBarre a occupé les postes de directeur de la biochimie analytique et protéique chez Biogen, Inc. et de directeur des sciences analytiques et de formulation chez IDEC Pharmaceuticals Corp. (une filiale de Biogen, Inc.) et vice-président du développement des produits chez Paramount BioSciences LLC. Le Dr LaBarre a obtenu un doctorat de l'université d'Arizona et un diplôme de premier cycle de l'université de Stony Brook.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
17/04/2024 | 168 176 ( 0,13% ) | 7 M $ | 31/03/2024 |
Postes actifs de Michael LaBarre
Sociétés | Poste | Début |
---|---|---|
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Anciens postes connus de Michael LaBarre
Sociétés | Poste | Fin |
---|---|---|
BIOGEN INC. | Corporate Officer/Principal | 01/04/2006 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 01/12/2003 |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - |
Formation de Michael LaBarre
Stony Brook University | Undergraduate Degree |
University of Arizona | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BIOGEN INC. | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |